Skip to main content

Table 2 Biochemical measurements of US data and Chinese populations

From: Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west?

 

US data (n = 11,844)

Chinese data (n = 51,229)

P value

(NHANES vs Chinese)

Total (n = 11,844)

non-NAFLD Group (n = 7571)

NAFLD Group (n = 4273)

P value

Total (n = 51,229)

non-NAFLD Group (n = 37,334)

NAFLD Group (n = 13,895)

P value

Serum cholesterol (mmol/l)

5.29 ± 1.18

5.21 ± 1.15

5.42 ± 1.22

< 0.001

4.71 ± 0.94

4.58 ± 0.90

5.04 ± 0.98

< 0.001

< 0.001

Serum triglyceride (mmol/l)

1.65 ± 1.28

1.56 ± 1.21

2.00 ± 1.46

< 0.001

1.57 ± 1.42

1.26 ± 1.02

2.39 ± 1.92

< 0.001

< 0.001

Uric acid (umol/l)

313.86 ± 87.36

306.04 ± 82.63

342.51 ± 97.66

< 0.001

307.37 ± 92.74

287.9 ± 86.75

359.69 ± 87.96

< 0.001

< 0.001

NFS

−2.09 ± 1.63

−2.36 ± 1.50

−1.10 ± 1.71

< 0.001

−1.76 ± 1.24

−1.83 ± 1.22

−1.55 ± 1.25

< 0.001

< 0.001

FIB4

0.93 ± 0.65

0.82 ± 0.56

1.30 ± 0.81

< 0.001

1.32 ± 0.85

1.31 ± 0.88

1.33 ± 0.75

0.010

< 0.001

APRI

0.21 ± 0.19

0.21 ± 0.19

0.22 ± 0.20

0.002

0.34 ± 0.26

0.31 ± 0.26

0.38 ± 0.24

< 0.001

< 0.001